Intensity Therapeutics(INTS) - 2025 Q4 - Annual Report

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or o TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 INTENSITY THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) | Delaware | 46-1488089 | | --- | --- | | (State or other jurisdiction of incorporation or organization ...